Please ensure Javascript is enabled for purposes of website accessibility

Better Marijuana Stock: Canopy Growth vs. Innovative Industrial Properties

By Keith Speights - Updated Apr 12, 2019 at 5:20PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Which stock wins in a match-up between a top Canadian marijuana producer and the leading U.S. cannabis-focused REIT?

It's nice to be No. 1. And both Canopy Growth (CGC -3.28%) and Innovative Industrial Properties (IIPR -3.01%) can lay claim to being at the top in different ways.

Canopy Growth is the largest marijuana producer in terms of market cap. Innovative Industrial Properties is the leading real estate investment trust (REIT) focused on the medical cannabis industry. 

But which of these marijuana stocks should be the No. 1 choice for investors? Here's how Canopy Growth and Innovative Industrial Properties stack up against each other.

Marijuana in a greenhouse

Image source: Getty Images.

The case for Canopy Growth

Check out the latest Canopy Growth earnings call transcript.

Perhaps the strongest argument for buying Canopy Growth is that the company should be able to deliver on part of its name: growth. Canopy's roots are in the Canadian medical marijuana market. Now, though, it's the Canadian recreational marijuana market that presents a huge opportunity for the company.

The problem right now in capitalizing on that opportunity is limited production capacity. Canopy Growth and its peers can't grow enough cannabis to keep up with demand. But that shouldn't be a problem for Canopy too much longer. The company is progressing toward its goal of 5.6 million square feet of production capacity across Canada. 

Canopy Growth isn't limited to Canada. The global medical marijuana market continues to expand rapidly. Canopy is a top player in several key markets, notably Germany.

In the past, Canopy couldn't establish operations in the U.S. because marijuana remained illegal at the federal level. But with the recent U.S. legalization of hemp (cannabis with low levels of psychoactive compound THC), Canopy now plans to quickly enter the U.S. market. Cannabis market-research firm Brightfield Group estimates that the U.S. hemp-based cannabidiol market could grow to $22 billion by 2022.

Funding an expansion into the lucrative U.S. market isn't an issue for Canopy Growth. Major alcoholic beverage company Constellation Brands invested $4 billion in 2018 to increase its stake in Canopy to around 38%. Not only does Canopy now have plenty of cash, the company also has a strong partner with expertise in building successful consumer brands. 

The case for Innovative Industrial Properties

Check out the latest Innovative Industrial Properties earnings call transcript.

Innovative Industrial Properties is delivering on part of its name, too. The company's focus on developing properties to lease to U.S. medical cannabis growers has provided an innovative solution for small marijuana businesses to get up and running.

Securing operating capital still can present some challenges for U.S. marijuana growers because federal laws restrict the ability of financial institutions to work with the cannabis industry. Innovative Industrial Properties provides the real estate capital needed.

In the process, Innovative Industrial Properties has achieved considerable financial success. The company is profitable. Its balance sheet is solid, with no debt. And it pays an attractive dividend that currently yields 3.13%.

Like Canopy Growth, Innovative Industrial Properties also should deliver strong growth. The company operates in nine states: Arizona, Colorado, Illinois, Maryland, Massachusetts, Michigan, Minnesota, New York, and Pennsylvania. At least four of these states should have marijuana markets topping $1 billion by 2022

The company is likely to continue its "rinse and repeat" business model. Revenue from lease payments from existing customers enables the REIT to invest in additional properties. With 31 states now with legalized medical marijuana and 10 states allowing recreational marijuana, Innovative Industrial Properties has lots of opportunities to offer its innovative real estate capital alternatives to customers.

The better marijuana stock

Innovative Industrial Properties claims several advantages over Canopy Growth. As previously mentioned, it's profitable and pays a nice dividend. The company can also operate in the U.S. marijuana market (and not just the hemp market). And its valuation is much more reasonable than Canopy's is. Because of these factors, I think that Innovative Industrial Properties is the better marijuana stock right now.

However, I remain bullish long term on Canopy Growth. The company's relationship with Constellation Brands should enable it to be a big winner in the global marijuana market for a long time. While I think Innovative Industrial Properties has the edge for now, both of these stocks appear to be good picks for investors seeking to profit from the marijuana boom.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends Constellation Brands and Innovative Industrial Properties. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Canopy Growth Stock Quote
Canopy Growth
$3.69 (-3.28%) $0.12
Innovative Industrial Properties Stock Quote
Innovative Industrial Properties
$98.62 (-3.01%) $-3.06

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/19/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.